Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the quick ratio (acid-test) high or low?
The quick ratio (acid-test) of 14.93 is 28% above its 3-year average of 11.65, around the middle of its 3-year range (6.51–32.01).
As of the fiscal period ended Tuesday, June 30, 2026. 8.39% above its 12-month average of 13.77.
Reported quarterly quick ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 14.93.
QUICK RATIO (ACID-TEST)
14.93
QUICK RATIO (ACID-TEST) AVG TTM
13.77
QUICK RATIO (ACID-TEST) AVG 3Y
11.65
QUICK RATIO (ACID-TEST) AVG 5Y
N/A
QUICK RATIO (ACID-TEST) AVG 10Y
N/A
QUICK RATIO (ACID-TEST) AVG 15Y
N/A
QUICK RATIO (ACID-TEST) AVG 20Y
N/A
CURRENT VS TTM AVG
+8.39%
CURRENT VS 3Y AVG
+28.16%
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.35
median of 871 covered companies
CURRENT VS SECTOR MEDIAN
+345.59%
vs the sector median at left
Jade Biosciences, Inc.
Market Cap
$802.34M
Quick Ratio (Acid-Test)
14.93
TTM Avg
13.77
3Y Avg
11.65
5Y Avg
N/A
Market Cap
$810.26M
Quick Ratio (Acid-Test)
3.15
TTM Avg
4.21
3Y Avg
3.84
5Y Avg
4.13
Market Cap
$788.23M
Quick Ratio (Acid-Test)
3.86
TTM Avg
4.02
3Y Avg
3.56
5Y Avg
3.80
Market Cap
$781.63M
Quick Ratio (Acid-Test)
0.98
TTM Avg
0.95
3Y Avg
0.97
5Y Avg
0.95
Market Cap
$826.35M
Quick Ratio (Acid-Test)
7.96
TTM Avg
6.81
3Y Avg
6.62
5Y Avg
6.62
Market Cap
$777.59M
Quick Ratio (Acid-Test)
1.53
TTM Avg
1.83
3Y Avg
2.05
5Y Avg
1.98
Market Cap
$775.02M
Quick Ratio (Acid-Test)
5.16
TTM Avg
4.89
3Y Avg
3.82
5Y Avg
4.31
Market Cap
$775.12M
Quick Ratio (Acid-Test)
13.29
TTM Avg
5.16
3Y Avg
5.49
5Y Avg
4.89
| NAME | MARKET CAP | QUICK RATIO (ACID-TEST) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Jade Biosciences, Inc. (JBIO) | $802.34M | 14.93 | 13.77 | 11.65 | N/A |
| InMode Ltd. (INMD)vs › | $803.27M | 7.28 | 9.00 | 9.42 | 9.03 |
| Ardelyx, Inc. (ARDX)vs › | $810.26M | 3.15 | 4.21 | 3.84 | 4.13 |
| Gyre Therapeutics, Inc. (GYRE)vs › | $788.23M | 3.86 | 4.02 | 3.56 | 3.80 |
| AdaptHealth Corp. (AHCO)vs › | $781.63M | 0.98 | 0.95 | 0.97 | 0.95 |
| Beta Bionics, Inc. (BBNX)vs › | $826.35M | 7.96 | 6.81 | 6.62 | 6.62 |
| Varex Imaging Corporation (VREX)vs › | $777.59M | 1.53 | 1.83 | 2.05 | 1.98 |
| Geron Corporation (GERN)vs › | $775.02M | 5.16 | 4.89 | 3.82 | 4.31 |
| Lexicon Pharmaceuticals, Inc. (LXRX)vs › | $775.12M | 13.29 | 5.16 | 5.49 | 4.89 |
| Monte Rosa Therapeutics, Inc. (GLUE)vs › | $829.71M | 9.52 | 4.26 | 6.09 | 7.80 |
Quick Ratio
14.93
Excludes inventory
Current Ratio
14.93
Includes inventory
Quick Ratio = (Current Assets − Inventory) / Current Liabilities
The quick ratio is a stricter liquidity measure that excludes inventory, showing the ability to meet short-term obligations with the most liquid assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | QUICK RATIO (ACID-TEST) |
|---|---|
| 2026-06-30 | 14.93 |
| 2026-03-31 | 14.29 |
| 2025-12-31 | 20.33 |
| 2025-09-30 | 9.01 |
| 2025-06-30 | 10.31 |
| 2025-03-31 | 32.01 |
| 2024-12-31 | 20.93 |
| 2024-09-30 | 8.78 |
| 2024-06-30 | 6.51 |
| 2024-03-31 | 6.65 |
| 2023-12-31 | 7.04 |
| 2023-09-30 | 9.34 |
